Literature DB >> 9217294

Role of dihydropyridine sensitive calcium channels in glucose transport in skeletal muscle.

J C Young1, T W Balon.   

Abstract

Glucose transport in skeletal muscle is a carrier-mediated process activated by insulin and by contractile activity. Since previous evidence suggests a role for calcium influx in the activation of this process, the purpose of this study was to determine if glucose transport is mediated by muscle's voltage dependent (dihydropyridine sensitive) calcium channels. Soleus and extensor digitorum longus (EDL) muscles, isolated from rats, were incubated with the calcium channel blocker nifedipine. Basal glucose transport was decreased in both soleus and EDL by nifedipine. Treatment with nifedipine effectively blocked both insulin and contraction stimulated glucose transport in soleus. Conversely, glucose transport in EDL, although reduced, was still significantly increased over basal by both insulin and contraction, due, perhaps, to a relatively greater number of dihydropyridine receptors in EDL. These results provide evidence that contraction stimulated, as well as insulin stimulated, glucose transport is mediated in-part by dihydropyridine receptors in skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9217294     DOI: 10.1016/s0024-3205(97)00390-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  Insulin increases near-membrane but not global Ca2+ in isolated skeletal muscle.

Authors:  J D Bruton; A Katz; H Westerblad
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

2.  GLP-2 potentiates L-type Ca2+ channel activity associated with stimulated glucose uptake in hippocampal neurons.

Authors:  Yi Wang; Xinfu Guan
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-11-17       Impact factor: 4.310

3.  Different exercise protocols improve metabolic syndrome markers, tissue triglycerides content and antioxidant status in rats.

Authors:  José D Botezelli; Lucieli T Cambri; Ana C Ghezzi; Rodrigo A Dalia; Pedro P M Scariot; Carla Ribeiro; Fabrício A Voltarelli; Maria Ar Mello
Journal:  Diabetol Metab Syndr       Date:  2011-12-19       Impact factor: 3.320

4.  Effects of 4 weeks recombinant human growth hormone administration on insulin resistance of skeletal muscle in rats.

Authors:  Mi Jung Park; Su Ryun Jung; Hyun Lyung Jung; Bruce W Craig; Chong-Do Lee; Ho Youl Kang
Journal:  Yonsei Med J       Date:  2008-12-31       Impact factor: 2.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.